Boston-based synthetic biology startup Ginkgo BioWorks has been selected as one of two entities to support a Scottish initiative to find better ways to assemble synthetic DNA, according to ITI Life Sciences, which has committed $4.1 million to the effort. ITI Life Sciences is a unit of ITI Scotland, a firm that was formed in 2003 by the government of Scotland to help grow industries in the country such as life sciences, energy, and digital media. Ginkgo BioWorks was launched in 2008 by five MIT scientists and researchers to make the construction of synthetic DNA easier and faster, according to its website.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
